This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van der Meer, P. Articles by van Veldhuisen, D. J. Search for Related Content PubMed PubMed Citation Articles by van der Meer, P. Articles by van Veldhuisen, D. J.

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

Peter van der Meer, MD^*,*, Adriaan A. Voors, MD^*, Erik Lipsic, MD^*, Tom D. J. Smilde, MD^*, Wiek H. van Gilst, PhD and Dirk J. van Veldhuisen, MD, FACC^*

^* Department of Cardiology, University Hospital Groningen, Groningen, the Netherlands
Department of Clinical Pharmacology, University of Groningen, Groningen, the Netherlands

View larger version (17K): [in a new window]   Figure 1 (a) Correlation between logarithm (log) (erythropoietin [EPO]) and hemoglobin in the chronic heart failure (CHF) cohort. (b) Correlation between log (EPO) and hemoglobin in the control patients.

View larger version (12K): [in a new window]   Figure 2 Kaplan-Meier survival curve for congestive heart failure patients with and without anemia.

View larger version (12K): [in a new window]   Figure 3 Kaplan-Meier survival curve for the congestive heart failure cohort by erythropoietin (EPO) level.